The Trans-Pacific Partnership agreement and public health: Why we should be concerned

Open Medicine

Volumn 8, Issue 3, 2014, Pages 100-101

  Schram, Ashley ^a   Labonte, Ronald ^b   Khatter, Kapil ^b  

^a UNIVERSITY OF OTTAWA   (Canada)

^b UNIVERSITY OF OTTAWA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CANADA; COMMERCIAL PHENOMENA; INTERNATIONAL COOPERATION; INTERPERSONAL COMMUNICATION; PACIFIC OCEAN; PUBLIC HEALTH;

CANADA; COMMERCE; INTERNATIONAL COOPERATION; NEGOTIATING; PACIFIC OCEAN; PUBLIC HEALTH;

EID: 84907326961     PISSN: None     EISSN: 19112092     Source Type: Journal    
DOI: None     Document Type: Editorial

References (10)

1. Barfield C. The TPP: A model for 21st century trade agreements? East Asia Forum. 2011; July 25. Available from: www.eastasiaforum.org/2011/07/25/the-tpp-a-model-for-21st-century-trade-agreements(accessed29July 2014)
2. Lexchin J, Gagnon MA. CETA and pharmaceuticals: impact of the trade agreement between Europe and Canada on the costs of patented drugs [briefing paper]. Ottawa: Canadian Centre for Policy Alternatives; 2013. Available from: www.policyalternatives.ca/sites/default/files/uploads/publications/National%20Office/2013/10/CETA_and_Pharmaceuticals.pdf(accessed27July2014).
3. Baker BK. Corporate power unbound: investor-state arbitration of IP monopolies on medicines - Eli Lilly and the TPP. [Internet] PIJIP Res Pap Ser 2013 May; (13). Available from: http://digitalcommons.wcl.american.edu/research/36(accessed27July2014)
4. Table of foreign investor-state cases and claims under NAFTA and other U.S. "trade" deals. Washington (DC): Public Citizen; 2014 June. Available from:www.citizen.org/documents/investor-state-chart.pdf(accessed27July2014)
5. Eberhardt P, Olivet C. Profiting from injustice: how law firms, arbitrators and financiers are fuelling an investment arbitration boom. Brussels/ Amsterdam: Corporate Europe Observatory and the Transnational Institute; 2012. Available from: www.tni.org/briefing/profitinginjustice accessed27July2014)
6. Berenbaum A, Folkins P. Eli Lilly files notice of arbitration in $500M NAFTA dispute against Canada. [Internet] New York: Mondaq; 2013 Sept 24. Available from: www.mondaq.com/canada/x/264620/Patent/Eli+Lilly+Files+Notice+Of+Arbitration+In+500M+NAFTA+Dispute+Against+Canada (accessed 27 July 2014).
7. Aumand L. Court of appeal tempers "promise of the patent" doctrine. [Internet] Ottawa: Gowlings; 2013 July. Available from: www.gowlings.com/KnowledgeCentre/article.asp?pubID=2966(accessed27July2014).
8. Khor M. Investor treaties in trouble. Star Online (Toronto) [Internet] 2014 Mar 24. Available from: www.thestar.com.my/Opinion/ Columnists/Global-Trends/Profile/Articles/2014/03/24/Investor-treaties-in-trouble(accessed27July2014).
9. "Improving ISDS to prevent abuse": statement by EU Trade Commissioner Karel De Gucht on the launch of a public consultation on investment protection in TTIP [news release]. Brussels: European Commission; 2014 Mar 27. Available from: http://europa.eu/rapid/press-release_STATEMENT-14-85_en.htm (accessed27July2014).
10. Schewel M. EU, Canada fail to close CETA; stuck over issue related to Eli Lilly case. Inside US Trade 2014; May 9.